ARCHIVES

Dendritic Cell Vaccine May Boost Median Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Project Enlists PC Users In Quest For Cancer Drugs.

April 6, 2001

“What Is Good For NCI Is Good For NIH,” Broder Says In Address

January 13, 1995

Aromasin Approved By FDA For ER+ Early Breast Cancer

October 28, 2005

NCI-Approved Cancer Center, Cooperative Group Trials

December 28, 2007

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

AACR Changes Its Logo— For The Fifth Time Since 2000

June 11, 2014